51 – 60 of 61
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis.
(
- Contribution to journal › Article
- 2010
-
Mark
Immune responses against aldehyde-modified laminin accelerate atherosclerosis in Apoe(-/-) mice.
(
- Contribution to journal › Article
- 2009
-
Mark
Immune responses against fibronectin modified by lipoprotein oxidation and their association with cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.
(
- Contribution to journal › Article
-
Mark
Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells.
(
- Contribution to journal › Article
- 2008
-
Mark
Cystatin C and cathepsins in cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
Inflammation and immunity in diabetic vascular complications.
(
- Contribution to journal › Article
-
Mark
Elastin- and Collagen-Rich Human Carotid Plaques Have Increased Levels of the Cysteine Protease Inhibitor Cystatin C.
(
- Contribution to journal › Article
- 2005
-
Mark
Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.
(
- Contribution to journal › Article
-
Mark
Lack of the Cysteine-Protease Inhibitor Cystatin C Promotes Atherosclerosis in Apolipoprotein E-Deficient Mice.
(
- Contribution to journal › Article